The 144 references in paper A. Bobylev A., S. Rachina A., S. Avdeev N., R. Kozlov S., N. Dekhnich N., А. Бобылев А., С. Рачина А., С. Авдеев Н., Р. Козлов С., Н. Дехнич Н. (2015) “Внебольничная пневмония у пациентов пожилого и старческого возраста // Community-acquired pneumonia in elderly and very elderly patients” / spz:neicon:pulmonology:y:2015:i:3:p:261-276

1
Trotter C.L., Stuart J.M., George R., Miller E. Increasing hospital admissions for pneumonia, England. Emerg. Infect. Dis.2008; 14 (5): 727–733.
(check this in PDF content)
2
Чучалин А.Г. Клинические рекомендации. Пульмонология. М.: ГЭОТАР-Медиа; 2005. / Chuchalin A.G. Clinical guidelines, Pulmonology. Moscow: GEOTARMedia; 2005 (in Russian).
(check this in PDF content)
3
Чучалин А.Г. Респираторная медицина. М.: ГЭОТАРМедиа; 2007. / Chuchalin A.G. Respiratory Medicine. Moscow: GEOTAR-Media; 2007 (in Russian).
(check this in PDF content)
4
Torres A., Peetermans W.E., Viegi G. et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013; 68 (11):1057–1065.
(check this in PDF content)
5
Brown J.S. Community-acquired pneumonia.Clin. Med. 2012; 12 (6): 538–643.
(check this in PDF content)
6
Steel H.C., Cockeran R., Anderson R. et al. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm.2013; 2013: 490346.
(check this in PDF content)
7
Gau J., Acharya U., Khan S. et al. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr.2010; 10: 45.
(check this in PDF content)
8
Sopena N., Pedro-Botet L., Mateu L. et al. Communityacquired legionella pneumonia in elderly patients: characteristics and outcome. J. Am. Geriatr. Soc.2007; 55 (1): 114–119.
(check this in PDF content)
9
Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart. 2007; 93 (9): 1137–1146.
(check this in PDF content)
10
Thomsen R.W., Riis A., Nørgaard M. et al. Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J. Intern. Med.2006; 259: 410–417.
(check this in PDF content)
11
Thomsen R.W., Kasatpibal N., Riis A. et al. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J. Gen. Intern. Med. 2008; 23 (9): 1407–1413.
(check this in PDF content)
12
Jackson M.L., Neuzil K.M., Thompson W.W. et al. The burden of community-acquired pneumonia in seniors: results of a population-based study.Clin. Infect. Dis.2004, 39: 1642–1650. Бобылев А.А. и др.Внебольничная пневмония у пациентов пожилого и старческого возраста
(check this in PDF content)
13
Piazza G., Seddighzadeh A., Goldhaber S.Z. Heart failure in patients with deep vein thrombosis. Am. J. Cardiol. 2008; 101 (7): 1056–1059.
(check this in PDF content)
14
Xiao K., Su L.X., Han B.C. et al. Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: a retrospective study. J. Thorac. Dis. 2013; 5 (5): 626–633.
(check this in PDF content)
15
Ishiguro T., Takayanagi N., Yamaguchi S. et al. Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Intern. Med.2013; 52 (3): 317–324.
(check this in PDF content)
16
García-Vázquez E., Soto S., Gómez J. et al. Simple criteria to assess mortality in patients with communityacquired pneumonia. Med. Clin.(Barc.). 2008; 131 (6): 201–204.
(check this in PDF content)
17
Corrales-Medina V.F., Musher D.M., Wells G.A. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012; 125 (6): 773–781.
(check this in PDF content)
18
Kondo A., Morinaga Y., Sasaki E. et al. Prognostic and risk factors in patients hospitalized with bacterial pneumonia. Kansenshogaku Zasshi. 2007; 81 (3): 268–275.
(check this in PDF content)
19
Welte T. Community-acquired pneumonia. Internist (Berl.). 2009; 50 (3): 331–339.
(check this in PDF content)
20
Welte T., Köhnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin. Respir. Crit. Care Med. 2009; 30 (2): 127–135.
(check this in PDF content)
21
Fujiki R., Kawayama T., Ueyama T. et. al. The risk factors for mortality of community-acquired pneumonia in Japan. J. Infect. Chemother. 2007; 13 (3): 157–165.
(check this in PDF content)
22
Fine M.J., Auble T.E., Yealy D.M. et al. A prediction rule to identify lowrisk patients with community-acquired pneumonia. N. Engl. J. Med.1997; 336: 243–250.
(check this in PDF content)
23
Lim W.S., van der Eerden M.M., Laing R. et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58: 377–382.
(check this in PDF content)
24
Liu L. Changes in cardiovascular hospitalization and comorbidity of heart failure in the United States: findings from the National Hospital Discharge Surveys 1980–2006. Int. J. Cardiol. 2011; 149 (1): 39–45.
(check this in PDF content)
25
Dai S., Walsh P., Wielgosz A. et al. Comorbidities and mortality associated with hospitalized heart failure in Canada. Can. J. Cardiol. 2012; 28 (1): 74–79.
(check this in PDF content)
26
Pei Z.Y., Zhao Y.S., Li J.Y. et al. Fifteen-year evolving trends of etiology and prognosis in hospitalized patients with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi. 2011; 39 (5): 434–439.
(check this in PDF content)
27
Viasus D., Garcia-Vidal C., Manresa F. et al. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J. Infect.2013; 66 (1): 27–33.
(check this in PDF content)
28
Musher D.M., Rueda A.M., Kaka A.S. et al. The association between pneumococcal pneumonia and acute cardiac events. Clin. Infect. Dis.2007; 45 (2): 158–165.
(check this in PDF content)
29
Becker T., Moldoveanu A., Cukierman T. et al. Clinical outcomes associated with the use of subcutaneous insulinby-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabet. Res. Clin. Pract. 2007; 78: 392–397.
(check this in PDF content)
30
Ramirez J., Aliberti S., Mirsaeidi M. et al. Acute myocardial infarction in hospitalized patients with communityacquired pneumonia. Clin. Infect. Dis.2008; 47: 182–187.
(check this in PDF content)
31
Perry T.W., Pugh M.J., Waterer G.W. et al. Incidence of cardiovascular events after hospital admission for pneumonia. Am. J. Med. 2011; 124: 244–251.
(check this in PDF content)
32
Mandal P., Chalmers J.D., Choudhury G. et al. Vascular complications are associated with poor outcome in community-acquired pneumonia. QJM. 2011; 104: 489–495.
(check this in PDF content)
33
Чучалин А.Г., Синопальников А.И., Страчунский Л.С. и др. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике.Клиническая микробиология и антимикробная химиотерапия.2006; 8 (1): 54–86. / Chuchalin A.G., Sinopal'nikov A.I., Strachunskiy L.S. et al. Community-acquired pneumonia in adults: guidelines on diagnosis, treatment and prevention. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2006; 8 (1): 54–86 (in Russian).
(check this in PDF content)
34
Maisel A., Neath S.X., Landsberg J. et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur. J. Heart Fail. 2012; 14 (3): 278–286.
(check this in PDF content)
35
Mueller C., Scholer A., Laule-Kilian K. et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.N. Engl. J. Med. 2004; 350: 647–654.
(check this in PDF content)
36
Dickstein K., Cohen-Solal A., Filippatos G. et al. The Task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008.Eur. Heart J. 2008; 29: 2388–2442.
(check this in PDF content)
37
Schneider H.G., Lam L., Lokuge A. et al. B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial. Ann. Intern. Med.2009; 150 (6): 365–371.
(check this in PDF content)
38
Villacorta H., Duarte A., Duarte N.M. et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq. Bras. Cardiol. 2002; 79 (6): 569–572, 564–568.
(check this in PDF content)
39
American Thoracic Society. ATS Statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111–117.
(check this in PDF content)
40
Deboeck G., Muylem A.V., Vachiéry J.L., Naeije R. Physiological response to the 6-minute walk test in chronic heart failure patients versus healthy control subjects. Eur. J. Prev. Cardiol. 2013; 21 (8): 997–1003.
(check this in PDF content)
41
JoséA., Corso S.D. Patients hospitalized for communityacquired pneumonia present reduced functional performance.Braz. J. Phys. Ther. 2013; 17 (4): 351–358.
(check this in PDF content)
42
Chong C.P., Street P.R. Pneumonia in the elderly: A review of the epidemiology, pathogenesis, microbiology, and clinical features. South Med. J.2008; 101: 1141–1145.
(check this in PDF content)
43
Fung H.B., Monteagudo-Chu M.O. Communityacquired pneumonia in the elderly. Am. J. Geriatr. Pharmacother. 2010; 8 (1): 47–62.
(check this in PDF content)
44
Mor A., Thomsen R.W., Ulrichsen S.P. et al. Chronic heart failure and risk of hospitalization with pneumonia: A population-based study. Eur. J. Intern.Med. 2013; 24: 349–353.
(check this in PDF content)
45
Ware L.B., Matthay M.A. Clinical practice. Acute pulmonary edema. N. Engl. J. Med.2005; 353: 2788–2796.
(check this in PDF content)
46
Marik P.E., Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003; 124: 328–336. Передовая статья
(check this in PDF content)
47
Sura L., Madhavan A., Carnaby G. et al. Dysphagia in the elderly: management and nutritional considerations. Clin. Interv. Aging.2012; 7: 287–298.
(check this in PDF content)
48
Janssens J.P., Krause K.H. Pneumonia in the very old. Lancet Infect. Dis.2004; 4: 112–124.
(check this in PDF content)
49
Zalacain R., Torres A., Celis R. et al. Communityacquired pneumonia in the elderly: Spanish multicentre study. Eur. Respir. J.2003; 21: 294–302.
(check this in PDF content)
50
Kaplan V., Angus D.C. Community-acquired pneumonia in the elderly. Crit. Care Clin.2003; 19: 729–748.
(check this in PDF content)
51
Bobylev A.A., Rachina S.A., Kozlov R.S., Belkova Y.A. Assessment of serum C-reactive protein level to improve community-acquired pneumonia diagnostics in patients with chronic heart failure. In: Proceedings of 25th European Congress of Clinical Microbiology and Infectious Diseases. Copenhagen, 25–28 Apr. 2015: 1436.
(check this in PDF content)
52
Gutiérrez F., MasiáM. Improving outcomes of elderly patients with community-acquired pneumonia. Drugs Aging.2008; 25 (7): 585–610.
(check this in PDF content)
53
Gutiérrez F., MasiáM. Rodriguez J.C. et al. Epidemiology of community-acquired pneumonia at the dawn of the twenty first century: a prospective study on the Mediterranean coast of Spain.Clin. Microbiol. Infect. 2005; 11: 788–800.
(check this in PDF content)
54
Kaplan V., Angus D.C., Griffin M.F. et al. Hospitalized community-acquired pneumonia in the elderly: Age- and sex-related patterns of care and outcome in the United States. Am. J. Respir. Crit. Care Med. 2002; 165: 766–772.
(check this in PDF content)
55
Woods G.L., Isaacs R.D., McCarroll K.A. et al. Ertapenem therapy for community-acquired pneumonia in the elderly.J. Am. Geriatr. Soc. 2003; 51: 1526–1532.
(check this in PDF content)
56
Vila-Corcoles A., Ochoa-Gondar O., Rodriguez-Blanco T. et al., for the EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: A population-based study. Respir. Med.2009; 103: 309–316.
(check this in PDF content)
57
El-Solh A.A., Pietrantoni C., Bhat A. et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am. J. Respir. Crit. Care Med.2003; 167: 1650–1654.
(check this in PDF content)
58
Lieberman D., Lieberman D. Community-acquired pneumonia in the elderly: A practical guide to treatment. Drugs Aging. 2000; 17: 93–105.
(check this in PDF content)
59
Garcia-Vazquez E., Marcos M.A., Mensa J. et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch. Intern. Med.2004; 164: 1807–1811.
(check this in PDF content)
60
Niederman M.S., Ahmed Q.A. Community-acquired pneumonia in elderly patients.Clin. Geriatr. Med.2003; 19: 101–120.
(check this in PDF content)
61
Gutiérrez F., MasiáM., Rodriguez J.C. et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin. Infect. Dis.2003; 36: 286–292.
(check this in PDF content)
62
Murdoch D.R. Diagnosis of Legionella infection. Clin. Infect. Dis. 2003; 36: 64–69.
(check this in PDF content)
63
Bellei N., Benfica D., Perosa A.H. et al. Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment. J. Virol. Methods.2003; 109: 85–88.
(check this in PDF content)
64
Murdoch D.R., Laing R.T., Mills G.D. et al. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J. Clin. Microbiol.2001; 39: 3495–3498.
(check this in PDF content)
65
Rodriguez J.C., MasiáM., Gutiérrez F. et al. Legionella pneumophila in community acquired pneumonia: interpretation of microbiological techniques (in Spanish). Med. Clin. (Barc.). 2004; 122: 277–278.
(check this in PDF content)
66
Monto A.S., Gravenstein S., Elliott M. et al. Clinical signs and symptoms predicting influenza infection.Arch. Intern. 2000; 160: 3243–3247.
(check this in PDF content)
67
Waterer G.W., Wunderink R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir. Med.2001; 95: 78–82.
(check this in PDF content)
68
Yu V.L., Chiou C.C., Feldman C. et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin. Infect. Dis.2003; 37: 230–237.
(check this in PDF content)
69
Campbell S.G., Marrie T.J., Anstey R. et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with communityacquired pneumonia: a prospective observational study. Chest. 2003; 123: 1142–1150.
(check this in PDF content)
70
Houck P.M., Bratzler D.W., Nsa W. et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 2004; 164: 637–644.
(check this in PDF content)
71
Mandell L.A., Wunderink R.G, Anzueto A. et al. Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44: 27–72.
(check this in PDF content)
72
Paganin F., Lilienthal F., Bourdin A. et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur. Respir. J.2004; 24: 779–785.
(check this in PDF content)
73
Metersky M.L., Ma A., Bratzler D.W. et al. Predicting bacteremia in patients with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2004; 169: 342–347.
(check this in PDF content)
74
Saito A., Kohno S., Matsushima T. et al. Prospective multicenter study of the causative organisms of communityacquired pneumonia in adults in Japan. J. Infect. Chemother.2006; 12: 63–69.
(check this in PDF content)
75
García-Ordóñez M.A., García-Jiménez J.M., Páez F. et al. Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 2001; 20: 14–19.
(check this in PDF content)
76
El-Solh A.A., Sikka P., Ramadan F. et al. Etiology of severe pneumonia in the very elderly. Am. J. Respir. Crit. Care Med. 2001; 163 (3, Pt 1): 645–651.
(check this in PDF content)
77
Gutiérrez F., MasiáM., Mirete C. et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens.J. Infect.2006; 53 (3): 166–174.
(check this in PDF content)
78
Kanwar M., Brar N., Khatib R. et al. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007; 131 (6): 1865–1869.
(check this in PDF content)
79
Basi S.K., Marrie T.J., Huang J.Q. et al. Patients admitted to hospital with suspected pneumonia and normal chest radiography. Epidemiology, microbiology and outcomes. Am. J. Med. 2004; 117: 305–311.
(check this in PDF content)
80
Loeb M.B., Carusone S.B., Marrie T.J. et al. Interobserver reliability of radiologists interpretations of mobile chest radiographs for nursing home-acquired pneumonia. J. Am. Med. Dir. Assoc.2006; 7: 416–419.
(check this in PDF content)
81
Albaum M.N., Hill L.C., Murphy M. et al. Interobserver reliability of the chest radiograph in community-acquired pneumonia. Chest. 1996; 110: 345–350. Бобылев А.А. и др.Внебольничная пневмония у пациентов пожилого и старческого возраста
(check this in PDF content)
82
Müller B., Harbarth S., Stolz D. et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.BMC Infect. Dis. 2007; 7: 10. DOI:10.1186/1471-2334-7-10.
(check this in PDF content)
83
Castro-Guardiola A., Armengou-Arxe A., Viejo-Rodriguez A. et al. Differential diagnosis between communityacquired pneumonia and non-pneumonia diseases of the chest in the emergency ward. Eur. J. Intern. Med.2000; 11: 334–339.
(check this in PDF content)
84
Lee Y.J., Lee J., Park Y.S. et al. Predictors of cardiogenic and non-cardiogenic causes in cases with bilateral chest infiltrates.Tuberc. Respir. Dis. (Seoul). 2013; 74: 15–22.
(check this in PDF content)
85
Israel H.L., Weiss W., Eisenberg G.M. et al. Delayed resolution of pneumonias. Med. Clin. N. Am. 1956; 40: 1291–1303.
(check this in PDF content)
86
Ali A., El Solh A.A., Alan T. et al. Radiographic Resolution of Community-Acquired Bacterial Pneumonia in the Elderly. J. Am. Geriatr. Soc.2004; 52 (2): 224–229.
(check this in PDF content)
87
Severs D., Moolenaar C., van Genderen P. Value of routine chest radiography in the diagnostic work-up of ill returned travelers. Intern. J. General Med.2012; 5: 1003–1008.
(check this in PDF content)
88
Madelon F.E., Paling E.P., Hoepelman A.I.M. et al. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. BMC Fam. Pract. 2012; 29: 383–393.
(check this in PDF content)
89
Holm A., Nexoe J., Bistrup L.A. et al. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br. J. Gen. Pract. 2007; 57: 547–554.
(check this in PDF content)
90
Macfarlane J., Holmes W., Gard P. et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001; 56: 109–114.
(check this in PDF content)
91
JoséV., Domingo M.L., Soto C. et al. Radiology of bacterial pneumonia. Eur. J. Radiol. 2004; 51: 102–113.
(check this in PDF content)
92
Tanaka N., Matsumoto T., Kuramitsu T. et al. High resolution CT findings in community-acquired pneumonia. J. Comput. Assist. Tomogr.1996; 20: 600–608.
(check this in PDF content)
93
Wheeler J.H., Fishman E.K. Computed tomography in the management of chest infections: current status. Clin. Infect. Dis. 1996; 23: 232–240.
(check this in PDF content)
94
SyrjäläH., Broas M., Suramo I. et al. High-resolution computed tomography for the diagnosis of communityacquired pneumonia. Clin. Infect. Dis.1998; 27: 358–363.
(check this in PDF content)
95
Volpicelli G., Cardinale L., Berchialla P. et al. A comparison of different diagnostic tests in the bedside evaluation of pleuritic pain in the ED. Am. J. Emerg. Med.2012; 30 (2): 317–324.
(check this in PDF content)
96
Esayag Y., Nikitin I., Bar-Ziv J. et al. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am. J. Med. 2010; 123 (1): 88.e1–88.e6.
(check this in PDF content)
97
Boyd A.R., Orihuela C.J. Dysregulated inflammation as a risk factor for pneumonia in the elderly. Aging Dis. 2011; 2 (6): 487–500.
(check this in PDF content)
98
Bruunsgaard H. The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Dan. Med. Bull.2006; 53 (3): 285–309.
(check this in PDF content)
99
Kelly E., MacRedmond R.E., Cullen G. et al Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia? Respirology. 2009; 14: 210–216.
(check this in PDF content)
100
Joffe E., Justo D., Mashav N. et al. C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin. Biochem.2009; 42 (16–17): 1628–1634.
(check this in PDF content)
101
Maruyama T., Gabazza E.C., Morser J. et al. Communityacquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir. Med.2010; 104 (4): 584–592.
(check this in PDF content)
102
Coelho L.M., Salluh J.I., Soares M. et al. Patterns of С-reactive protein RATIO response in severe communityacquired pneumonia: a cohort study. Crit. Care.2012; 16 (2): R53.
(check this in PDF content)
103
Lacoma A., Rodríguez N., Prat C. et al. Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis.2012; 31 (5): 825–833.
(check this in PDF content)
104
Menéndez R., Sahuquillo-Arce J.M., Reyes S. et al. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest. 2012; 141 (6): 1537–1545.
(check this in PDF content)
105
Berg P., Lindhardt B.Ø. The role of procalcitonin in adult patients with community-acquired pneumonia – a systematic review. Dan. Med. J.2012; 59 (3): A4357.
(check this in PDF content)
106
Almirall J., Bolíbar I., Toran P. et al. CommunityAcquired Pneumonia Maresme Study Group. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest. 2004; 125 (4): 1335–1342.
(check this in PDF content)
107
Cals J.W., Butler C.C., Hopstaken R.M. et al. Effect of point of care testing for C-reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. Br. Med. J. 2009; 338: 1112–1116.
(check this in PDF content)
108
Krüger S., Ewig S., Giersdorf S. et al. German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group. Cardiovascular and inflammatory biomarkers to predict short- and longterm survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ. Am. J. Respir. Crit. Care Med.2010; 182 (11): 1426–1434.
(check this in PDF content)
109
Schuetz P., Wolbers M., Christ-Crain M. et al.; ProHOSP Study Group. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.Crit. Care.2010; 14 (3): R106.
(check this in PDF content)
110
Schuetz P., Suter-Widmer I., Chaudri A. et al. Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) Study Group. Prognostic value of procalcitonin in community-acquired pneumonia. Eur. Respir. J. 2011; 37 (2): 384–392.
(check this in PDF content)
111
Christ-Crain M., Stolz D., Bingisser R. et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med. 2006; 174 (1): 84–93.
(check this in PDF content)
112
Schuetz P., Batschwaroff M., Dusemund F. et al. Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29 (3): 269–277.
(check this in PDF content)
113
Tang H., Huang T., Jing J. et al. Effect of procalcitoninguided treatment in patients with infections: a systematic review and meta-analysis. Infection. 2009; 37 (6): 497–507.
(check this in PDF content)
114
Meehan T.P., Fine M.J., Krumholz H.M. et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997; 278: 2080–2084.
(check this in PDF content)
115
Benenson R., Magalski A., Cavanaugh S. et al. Effects of a pneumonia clinical pathway on time to antibiotic treatПередовая статья ment, length of stay, and mortality. Acad. Emerg. Med. 1999; 6: 1243–1248.
(check this in PDF content)
116
Marrie T.J., Wu L. Factors influencing in hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest. 2005; 127: 1260–1270.
(check this in PDF content)
117
Gleason P.P., Meehan T.P., Fine J.M. et al. Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med.1999; 159: 2562–2572.
(check this in PDF content)
118
Houck P.M., MacLehose R.F., Niederman M.S. et al. Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest. 2001; 119: 1420–1426.
(check this in PDF content)
119
Grossman R.F., Campbell D.A., Landis S.J. et al. Treatment of community-acquired pneumonia in the elderly: the role of cefepime, a fourth-generation cephalosporin. J. Antimicrob. Chemother. 1999; 43 (4): 549–554.
(check this in PDF content)
120
Wilson B.Z., Anzueto A., Restrepo M.I. et al. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe communityacquired pneumonia. Crit. Care Med.2012; 40 (8): 2310–2314.
(check this in PDF content)
121
Чучалин А.Г., Синопальников А.И., Козлов Р.С. и др. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике: Пособие для врачей. М.:РРО, МАКМАХ; 2010. / Chuchalin A.G., Sinopal'nikov A.I., Kozlov R.S. et al. Community-acquired pneumonia in adults: guidelines on diagnosis, treatment and prevention. Moscow: RRO, MAKMAKh; 2010 (in Russian).
(check this in PDF content)
122
Romanelli G., Cravarezza P., Pozzi A. et al. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.J. Chemother. 2002; 14 (6): 609–617.
(check this in PDF content)
123
Bradley J.S., Garau J. Lode H. et al. Carbapenems in clinical practice: a guide to their use in serious infection. Intern. Int. J. Antimicrob. Agents. 1999; 11 (2): 93–100.
(check this in PDF content)
124
Murcia J.M., Gonzalez-Comeche J., Marin A. et al. Clinical response to ertapenem in severe communityacquired pneumonia: a retrospective series in an elderly population.Clin. Microbiol. Infect. 2009; 15: 1046–1050.
(check this in PDF content)
125
Yanagihara K., Fukuda Y., Seki M. et al. Clinical comparative study of sulbactam / ampicillin and imipenem / cilastatin in elderly patients with communityacquired pneumonia.Intern. Med.2006; 45 (17): 995–999. DOI: 10.2169/ internalmedicine.45.1717.
(check this in PDF content)
126
Shorr A.F., Zadeikis N., Xiang J.X. et al. A multicenter, randomized, double-blind, retrospective comparison of 5and 10-day regimens of levofloxacin in a subgroup of patients aged ≥65 years with community–acquired pneumonia.Clin. Ther. 2005; 27: 1251-1259.
(check this in PDF content)
127
Finch R., Schurmann D., Collins O. et al. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral coamoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. Antimicrob. Agents Chemother.2002; 46 (6): 1746–1754.
(check this in PDF content)
128
Correa J.C., Badaro R., Bumroongkit C. et al. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.Clin. Ther. 2003; 25 (5): 1453–1468.
(check this in PDF content)
129
Frank E., Liu J., Kinasewitz G. et al. A multicenter, openlabel, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clin. Ther. 2002; 24 (8): 1292–1308.
(check this in PDF content)
130
Vardakas K.Z., Siempos I.I., Grammatikos A. et al. Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ. 2008; 179 (12): 1269–1277.
(check this in PDF content)
131
Ye X., Sikirica V., Schein J.R. et al. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Clin. Ther.2008; 30 (2): 358–371.
(check this in PDF content)
132
Anzueto A., Niederman M.S., Pearle J. et al. CommunityAquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clin. Infect. Dis.2006; 42: 73–81.
(check this in PDF content)
133
Dong K., Quan D.J. Appropriately assessing renal function for drug dosing. Nephrol. Nurs. J.2010; 37 (3): 304–308.
(check this in PDF content)
134
Murphree D.D., Thelen S.M. Chronic kidney disease in primary care.J. Am. Board. Fam. Med.2010; 23 (4): 542–550.
(check this in PDF content)
135
Olyaei A.J., Bennett W.M. Drug dosing in the elderly patients with chronic kidney disease. Clin. Geriatr. Med. 2009; 25 (3): 459–527.
(check this in PDF content)
136
Herring A.R., Williamson J.C. Principles of antimicrobial use in older adults. Clin. Geriatr. Med.2007; 23 (3): 481–497.
(check this in PDF content)
137
Faulkner C.M., Cox H.L., Williamson J.C. Unique aspects of antimicrobial use in older adults. Clin. Infect. Dis. 2005; 40 (7): 997–1004.
(check this in PDF content)
138
Shakeri-Nejad K., Stahlmann R. Drug interactions during therapy with three major groups of antimicrobial agents. Exp. Opin. Pharmacother.2006; 7 (6): 639–651.
(check this in PDF content)
139
Rubinstein E., Camm G. Cardiotoxicity of fluoroquinolones. J. Antimicrob. Chemother.2002; 49: 593–596.
(check this in PDF content)
140
Andriole V.T., Haverstock D.C., Choudhri S.H. et al. Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials. Drug. Safety. 2005; 28 (5): 443–452.
(check this in PDF content)
141
Ferrara A.M. A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP). Clin. Intervent. Aging.2007; 2 (2): 179–187.
(check this in PDF content)
142
Russo V., Puzio G., Siniscalchi N. et al. Azithromycininduced QT prolongation in elderly patient. Acta. Biomed. 2006; 77 (1): 30–32.
(check this in PDF content)
143
Morganroth J., DiMarco J.P., Anzueto A. et al. Randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest. 2005; 128: 3398–3406.
(check this in PDF content)
144
González-Castillo J., Martín-Sánchez F.J., Llinares P. et al. Guidelines for the management of communityacquired pneumonia in the elderly patient. Rev. Esp. Quimioter. 2014; 27 (1): 69–86. Поступила 22.06.15
(check this in PDF content)